PARP9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis, thus mediating proliferation, survival and chemo-resistance in DLBCL (Ref. Here, PARP9 is linked to diffuse large B-cell lymphoma.